PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Symptom | |hepatocellular carcinoma |
| Sentences | 261 |
| PubMedID- 21319289 | Second neoplasms appeared in 3 patients, 1 of whom died of hepatocellular carcinoma following infection with hepatitis b. |
| PubMedID- 23691458 | Found increased mir-196a expression among hepatocellular carcinoma patients with hepatitis b virus infection who carried the c allele . |
| PubMedID- 20087166 | hepatitis c prevalence in patients with hepatocellular carcinoma without cirrhosis. |
| PubMedID- 21160825 | Skull metastasis from hepatocellular carcinoma with chronic hepatitis b. |
| PubMedID- 23326737 | Fatal hepatocellular carcinoma in a patient with occult hepatitis b virus infection following the administration of r-chop for diffuse large b-cell lymphoma. |
| PubMedID- 22588449 | Skull metastasis from hepatocellular carcinoma with hepatitis c. |
| PubMedID- 23122451 | Is serum level of methylated rassf1a valuable in diagnosing hepatocellular carcinoma in patients with chronic viral hepatitis c. |
| PubMedID- 21720061 | We describe a case of a 69-year-old woman who developed rapidly progressive hepatocellular carcinoma (hcc) associated with autoimmune hepatitis (aih) after a 7-year follow-up. |
| PubMedID- 24704525 | Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis b: a nationwide cohort study. |
| PubMedID- 24248733 | Microrna-196a-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis b. |
| PubMedID- 26159441 | Background: this study was designed to evaluate the prognostic value of three systemic inflammation markers, neutrophil to lymphocyte ratio (nlr), platelet to lymphocyte ratio (plr), and prognostic nutritional index (pni), for hepatocellular carcinoma (hcc) associated with hepatitis b (hbv). |
| PubMedID- 20096126 | Previous studies pay more emphasis on changes of lipid metabolisms under chronic hepatitis and cirrhosis with or without hepatocellular carcinoma . |
| PubMedID- 24338810 | Most cases of hepatocellular carcinoma (hcc) are due to chronic hepatitis b virus (hbv) or hepatitis c virus (hcv) infection worldwide. |
| PubMedID- 22236533 | Similar to ulcerative colitis, 15% of gastrointestinal malignancies arise as a consequence of chronic microbial infections, as demonstrated by the raised chance of hepatocellular carcinoma in patients with chronic hepatitis, association between helycobacter pylori infection and higher gastric cancer risk, and increased chance of colon cancer in patients with inflammatory bowel disease . |
| PubMedID- 22688407 | Background: the occurrence of hepatocellular carcinoma (hcc) in patients with autoimmune hepatitis (aih) is rare compared to that in patients with viral hepatitis. |
| PubMedID- 22105231 | Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis c virus infection receiving interferon therapy: a single center study. |
| PubMedID- 22972059 | Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis b. |
| PubMedID- 25702656 | Fulminant hepatitis in a patient with hepatocellular carcinoma related to nonalcoholic steatohepatitis treated with sorafenib. |
| PubMedID- 24409059 | Aim: to study the potential association between hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc), cirrhosis and latent hepatitis b (lhb) infection, defined as the absence of detectable serum hepatitis b surface antigen (hbsag) and the presence of hepatitis b core antibody (hbcab). |
| PubMedID- 26305067 | A variant in pnpla3 associated with fibrosis progression but not hepatocellular carcinoma in patients with hepatitis c virus infection. |
| PubMedID- 21459723 | Gpc3 fused to an alpha epitope of hbsag acts as an immune target against hepatocellular carcinoma associated with hepatitis b virus. |
| PubMedID- 26191473 | In addition, dm has been suggested to enhance the development of hepatocellular carcinoma in patients with chronic hepatitis c (kawamura et al. |
| PubMedID- 24876745 | Several studies have been carried out to create risk calculators for the prediction of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b (chb). |
| PubMedID- 23907815 | Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis b. |
| PubMedID- 22879825 | hepatocellular carcinoma complicates 5% of the chronic hepatitis c cases . |
| PubMedID- 22212935 | Prevention of hepatocellular carcinoma in patients with chronic hepatitis b virus infection. |
| PubMedID- 25133046 | Prevention of hepatocellular carcinoma in patients with chronic hepatitis b. |
| PubMedID- 22439008 | stated that phlebotomy therapy may potentially lower the risk of progression to hepatocellular carcinoma (hcc) in patients with hepatitis c virus infection. |
| PubMedID- 22957141 | End-stage liver diseases as well as hepatocellular carcinoma attributable to chronic hepatitis c are increasingly serious problems2. |
| PubMedID- 26045707 | Conclusions: sustained virological response can reduce all-cause mortality and the incidence of hepatocellular carcinoma of patients with hepatitis c. |
| PubMedID- 21931376 | Objectives: prospective studies of serum hepatocellular carcinoma (hcc) biomarkers in patients with advanced hepatitis c are lacking. |
| PubMedID- 21278701 | The incidence of hepatocellular carcinoma associated with hepatitis c infection decreased after 2001 in kyushu area. |
| PubMedID- 23202460 | Glycyrrhizin, for instance, a component of licorice roots extract, has been shown to prevent the development of hepatocellular carcinoma in patients with chronic hepatitis . |
| PubMedID- 24159595 | Adjuvant therapy after curative resection for hepatocellular carcinoma associated with hepatitis virus. |
| PubMedID- 22659345 | Polymorphisms of dna repair genes in korean hepatocellular carcinoma patients with chronic hepatitis b: possible implications on survival. |
| PubMedID- 21563203 | Inactivation of klf6 is common in hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection, thereby abrogating its normal antiproliferative activity in liver cells. |
| PubMedID- 25469280 | Dm with insulin resistance is a risk factor for hepatocellular carcinoma (hcc) in patients with hepatitis c virus (hcv) infection. |
| PubMedID- 21170963 | Obesity and metabolic syndrome are recognized risk factors for development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc). |
| PubMedID- 21911898 | Liver cirrhosis and hepatocellular carcinoma in mexico: impact of chronic infection by hepatitis viruses b and c. |
| PubMedID- 26380927 | The aim of this study was to investigate the feasibility of using serum exosomal micrornas as novel serological biomarkers for hepatocellular carcinoma (hcc) in patients with chronic hepatitis b (chb). |
| PubMedID- 25373121 | Are selective serotonin reuptake inhibitors associated with hepatocellular carcinoma in patients with hepatitis c. |
| PubMedID- 23236406 | The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis b virus infection and cirrhosis. |
| PubMedID- 21526141 | We report a case of hepatocellular carcinoma (hcc) with chronic hepatitis c virus infection successfully treated with percutaneous radiofrequency ablation (rfa) under live four-dimensional (4d) echo guidance. |
| PubMedID- 20549250 | Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis b virus-related liver disease. |
| PubMedID- 21998681 | Kir and hla loci are associated with hepatocellular carcinoma development in patients with hepatitis b virus infection: a case-control study. |
| PubMedID- 21056500 | The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - a multicenter prospective trial. |
| PubMedID- 25657603 | In a recent report from our institution, we identified over a three-year period 3% (9/298) of ltx patients who developed severe hf after ltx.62 in these nine patients, etiology of liver failure was hepatitis c with hepatocellular carcinoma in four, hemochromatosis in four (with one showing evidence of iron deposition in the heart on biopsy), and one with primary biliary cirrhosis. |
| PubMedID- 21063480 | A case-control study on sequence variations in the enhancer ii/core promoter/precore and x genes of hepatitis b virus in patients with hepatocellular carcinoma. |
| PubMedID- 20368541 | Conclusion: these easy-to-use nomograms based on noninvasive clinical characteristics can accurately predict the risk of hepatocellular carcinoma in patients with chronic hepatitis b. |
| PubMedID- 20616578 | Impact of peginterferon maintenance therapy on the risk of developing hepatocellular carcinoma in patients with chronic hepatitis c virus. |